India's Glenmark Pharma falls after quarterly profit drop

Glenmark Pharmaceuticals

18/08/2025 06:28

** Shares of Glenmark Pharma GLEN.NS fall 1.45% to 2,014.9 rupees

** Drugmaker's Q1 consol PBT fell 9% to 4.19 bln rupees ($47.96 million), net sales down by 5% at 30.59 bln rupees hit by pricing pressure in North America and Europe

** Sales in North America slipped 0.4%, while that in Europe dropped 4% for the quarter

** Europe and Emerging markets businesses to deliver a double-digit growth from Q2 onwards, chairman says

** 9 analysts covering GLEN have a "buy" rating on average, median PT is 2,365 rupees - data compiled by LSEG

** Stock up ~25% YTD

($1 = 87.3675 Indian rupees)

 (Reporting by Urvi Dugar)

 ((UrviManoj.Dugar@thomsonreuters.com))